SCHEMBL765147

SCHEMBL765147

Bc1cc(Cl)ccc1Oc1ccc(CN)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ST14 Q9Y5Y6 3/20 0.50
MAOB P27338 4/20 0.47
MAPT P10636 3/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP2D6 P10635 1/20 0.47
HPGD P15428 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
FFAR1 O14842 1/20 0.43
MRGPRX4 Q96LA9 1/20 0.43
CYP3A4 P08684 1/20 0.42
HTR2A P28223 1/20 0.42
SLC6A4 P31645 1/20 0.42
KCNH2 Q12809 1/20 0.42
PNMT P11086 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12239005 0.83 FFAR1 (0.60) ST14MAOBMAPTCYP1A2CYP2C9
SCHEMBL13904298 0.81 MAOB (0.50) ST14MAOBHTR2ASLC6A4KCNH2
SCHEMBL765629 0.81 ST14 (0.50) ST14MAOBMAPTCYP1A2CYP2C9
SCHEMBL12239029 0.81 ST14 (0.50) ST14MAOBMAPTCYP1A2CYP2C9
SCHEMBL10121244 0.80 ST14 (0.53) ST14MAOBMAPTCYP1A2CYP2C9
SCHEMBL13904294 0.77 ST14 (0.50) ST14MAOBFFAR1MRGPRX4PDE7A
SCHEMBL12239032 0.77 ST14 (0.46) ST14MAOBMAPTCYP1A2CYP2C9
SCHEMBL921428 0.77 ST14 (0.68) ST14MAOBPNMTTAAR1
SCHEMBL13904297 0.76 ST14 (0.52) ST14MAOBALDH1A1TAAR1HTT
Hydrochloric Acid SCHEMBL6159403 0.75 MAOB (0.69) ST14MAOBMAPTCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2188254-B1 NOVEL BRADYKININ B1-ANTAGONISTS BOEHRINGER INGELHEIM INT (DE) 2012-03-21 EP disclosed
WO-2009027450-A1 NOVEL BRADYKININ B1-ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-03-05 WO disclosed